Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Andrews

Showing results (81-90 of 364) with videos related to

Pageof 37
Sort By:
Vaccine|May 13, 2014
Evaluating the potential risks and benefits of infant rotavirus vaccination in EnglandAndy Clark, Mark Jit, Nick Andrews, et al.
Statistics in Medicine|September 4, 2012
An improved algorithm for outbreak detection in multiple surveillance systemsAngela Noufaily, Doyo G Enki, Paddy Farrington, et al.
Plos One|July 21, 2012
Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypesAlbert Jan van Hoek, Nick Andrews, Pauline A Waight, et al.
The Journal of Infectious Diseases|November 17, 2006
Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United KingdomCressida Auckland, Stephen Gray, Ray Borrow, et al.
The Journal of Infection|August 28, 2007
Morbidity and mortality of pneumococcal meningitis and serotypes of causative strains prior to introduction of the 7-valent conjugant pneumococcal vaccine in EnglandAlan P Johnson, Pauline Waight, Nick Andrews, et al.
Plos One|June 16, 2018
Bias due to differential and non-differential disease- and exposure misclassification in studies of vaccine effectivenessTom De Smedt, Elizabeth Merrall, Denis Macina, et al.
JAMA|December 7, 2020
Stillbirths During the COVID-19 Pandemic in England, April-June 2020Julia Stowe, Helen Smith, Kate Thurland, et al.
Vaccine|June 25, 2011
A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and DenmarkNick Andrews, Julia Stowe, Elizabeth Miller, et al.
BMJ Global Health|May 20, 2021
Methodological frontiers in vaccine safety: qualifying available evidence for rare events, use of distributed data networks to monitor vaccine safety issues, and monitoring the safety of pregnancy interventionsCaitlin Dodd, Nick Andrews, Helen Petousis-Harris, et al.
Plos Medicine|September 14, 2020
Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage studyJulia Stowe, Nick Andrews, Paul Gringras, et al.
Pageof 37

Showing results (81-90 of 364) with videos related to

Sort By:
Pageof 37
Vaccine|May 13, 2014
Evaluating the potential risks and benefits of infant rotavirus vaccination in EnglandAndy Clark, Mark Jit, Nick Andrews, et al.
Statistics in Medicine|September 4, 2012
An improved algorithm for outbreak detection in multiple surveillance systemsAngela Noufaily, Doyo G Enki, Paddy Farrington, et al.
Plos One|July 21, 2012
Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypesAlbert Jan van Hoek, Nick Andrews, Pauline A Waight, et al.
The Journal of Infectious Diseases|November 17, 2006
Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United KingdomCressida Auckland, Stephen Gray, Ray Borrow, et al.
The Journal of Infection|August 28, 2007
Morbidity and mortality of pneumococcal meningitis and serotypes of causative strains prior to introduction of the 7-valent conjugant pneumococcal vaccine in EnglandAlan P Johnson, Pauline Waight, Nick Andrews, et al.
Plos One|June 16, 2018
Bias due to differential and non-differential disease- and exposure misclassification in studies of vaccine effectivenessTom De Smedt, Elizabeth Merrall, Denis Macina, et al.
JAMA|December 7, 2020
Stillbirths During the COVID-19 Pandemic in England, April-June 2020Julia Stowe, Helen Smith, Kate Thurland, et al.
Vaccine|June 25, 2011
A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and DenmarkNick Andrews, Julia Stowe, Elizabeth Miller, et al.
BMJ Global Health|May 20, 2021
Methodological frontiers in vaccine safety: qualifying available evidence for rare events, use of distributed data networks to monitor vaccine safety issues, and monitoring the safety of pregnancy interventionsCaitlin Dodd, Nick Andrews, Helen Petousis-Harris, et al.
Plos Medicine|September 14, 2020
Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage studyJulia Stowe, Nick Andrews, Paul Gringras, et al.
Pageof 37